Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 9, 2016 - Issue 9
Submit an article Journal homepage
182
Views
8
CrossRef citations to date
0
Altmetric
Review

Avanafil - a further step to tailoring patient needs and expectations

Luca BoeriDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
,
Paolo CapogrossoUniversità Vita-Salute San Raffaele & Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
,
Eugenio VentimigliaUniversità Vita-Salute San Raffaele & Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
,
Alessandro SerinoDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
,
Giovanni La CroceUniversità Vita-Salute San Raffaele & Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
,
Andrea RussoUniversità Vita-Salute San Raffaele & Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
,
Rocco DamianoDepartment of Urology, Research Doctorate Program in Urology, Magna Graecia University, Catanzaro, Italy
,
Francesco MontorsiUniversità Vita-Salute San Raffaele & Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
&
Andrea SaloniaUniversità Vita-Salute San Raffaele & Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, ItalyCorrespondence[email protected]
 show all
Pages 1171-1181 | Received 02 Apr 2016, Accepted 25 May 2016, Published online: 13 Jun 2016

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mattia Longoni, Alessandro Bertini, Nicolò Schifano, Emanuele Zaffuto, Paolo Maggio, Rossi Piercarlo, Sara Baldini, Giulio Carcano, Gabriele Antonini, Andrea Salonia, Francesco Montorsi, Federico Dehò & Paolo Capogrosso. (2023) A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies. Expert Opinion on Pharmacotherapy 24:12, pages 1375-1386.
Read now

Articles from other publishers (7)

Mohammadsadegh Hamzehnejadi, Marziye Ranjbar Tavakoli, Ardavan Abiri, Ali Ghasempour, Mohammad Amin Langarizadeh & Hamid Forootanfar. (2022) A Review on Phosphodiesterase-5 Inhibitors as a Topical Therapy for Erectile Dysfunction. Sexual Medicine Reviews 10:3, pages 376-391.
Crossref
Manish Kumar, Amey D Pathade, S VijayaBhaskara Gupta, Sanjay Goyal, Debadarshi Rath, Manish Thakre, Jayesh Sanmukhani & Ravindra Mittal. (2022) Efficacy and safety of avanafil as compared with sildenafil in the treatment of erectile dysfunction: A randomized, double blind, multicenter clinical trial. International Journal of Urology 29:4, pages 351-359.
Crossref
Yurii Gurzhenko & Volodymyr Spyrydonenko. (2021) Theoretical Substantiation of the Use of Sildenafil in the Treatment of Chronic Prostatitis. Health of Man:2, pages 58-62.
Crossref
Walter Cazzaniga, Paolo Capogrosso, Luca Boeri, Francesco Montorsi & Andrea Salonia. 2020. Urologic Principles and Practice. Urologic Principles and Practice 159 174 .
В. В. Спиридоненко. (2019) Avanafil – a New Means for Treating Erectile Dysfunction in the Ukraine Market. Health of Man:4, pages 57-62.
Crossref
Giovanni Corona, Mario Maggi & Emmanuele A. Jannini. (2018) EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil. Sexual Medicine 6:1, pages 15-23.
Crossref
Andrea Salonia, Ganesh Adaikan, Jacques Buvat, Serge Carrier, Amr El-Meliegy, Kostas Hatzimouratidis, Andrew McCullough, Abraham Morgentaler, Luiz Otavio Torres & Mohit Khera. (2017) Sexual Rehabilitation After Treatment For Prostate Cancer—Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). The Journal of Sexual Medicine 14:3, pages 297-315.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.